Viral entry and replication machinery

Viral entry and replication machinery refers to the collective set of viral and host-derived components required for a virus to successfully infect a cell and produce progeny [1]. This machinery includes entry-related proteins like viral glycoproteins and host receptors (e.g., ACE2 for SARS-CoV-2), as well as replication-related enzymes such as RNA-dependent RNA polymerases (RdRp) and proteases [2]. Because this term encompasses a wide variety of distinct molecular entities across different viral families, it is classified as a functional group rather than a single therapeutic target [3]. Antiviral therapies target specific nodes within this machinery to disrupt the viral life cycle, such as entry inhibitors (e.g., Maraviroc) or replication inhibitors (e.g., Remdesivir) [4]. A major challenge in targeting these processes is the rapid evolution of viruses, which frequently leads to resistance mutations in the targeted machinery [5]. Sources: [1] Nature Education. Virus Entry into Host Cells. [2] StatPearls. Viral Replication. [3] NIH NIAID. Antiviral Drug Development. [4] Nature Reviews Drug Discovery. The landscape of antiviral therapeutics. [5] PubMed. Mechanisms of Viral Resistance.

Other names

Viral life cycle machineryViral replication complexViral entry proteinsViral replication apparatus

Inhibition of various stages of the viral life cycle, including attachment, fusion, uncoating, nucleic acid synthesis, and polyprotein processing [4].